Significant Relation of Tissue Inhibitor of Matrix Metalloproteinase-2 and Its Combination With Matrix Metalloproteinase-2 to Survival of Patients With Cancer of Uterine Cervix
- 1 August 2011
- journal article
- Published by Springer Nature in Reproductive Sciences
- Vol. 18 (8) , 798-808
Abstract
Tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) has high affinity for matrix metalloproteinase-2 (MMP-2). Few studies simultaneously investigate their implication in prognosis of patients with cervical cancer. We used reverse transcription-polymerase chain reaction and immunohistochemical method for cervical tissues and microarrays to investigate the association among TIMP-2, MMP-2, clinicopathological parameters, and prognosis of patients with cancer. Our results showed that cancer tissues exhibited less TIMP-2 expression and patients with pelvic lymph node metastasis had less TIMP-2 expression. Positive TIMP-2 constellated with negative MMP-2 indicated lower recurrence probability and better overall survival. The protective effect of TIMP-2 expression may overcome the adverse effect of MMP-2 expression in terms of disease-free interval and overall survival while neither TIMP-2 nor MMP-2 alone can be used to predict outcome. We suggest that following patients other than those with positive TIMP-2 and negative MMP-2 expression more closely and intensely may improve their prognosis.Keywords
This publication has 33 references indexed in Scilit:
- Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized femalesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signalingMolecular Cancer, 2009
- Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potentialBMC Cancer, 2009
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- Using a combination of cytochrome P450 1B1 and β-catenin for early diagnosis and prevention of colorectal cancerCancer Detection Prevention, 2005
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- AdTIMP-2 Inhibits Tumor Growth, Angiogenesis, and Metastasis, and Prolongs Survival in MiceHuman Gene Therapy, 2001
- Microinvasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia: Biologic Significance and Clinical Implications of 72-kDa Metalloproteinase ImmunostainingGynecologic Oncology, 1996
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995
- Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the OvaryAmerican Journal of Surgical Pathology, 1992